Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/03
End: 02/28/06
Due: 02/28/07
Phase: N/A
Priority: Normal
Start: 09/30/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/03
End: 03/31/07
Due: 03/31/08
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation | NCT00063310 | Voyager Pharmaceutical Corporation | user2@example.com | None | 2003-03-31 | 2006-02-28 | 2007-02-28 | - | - | 2025-07-14 |
| ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301) | NCT00231946 | Voyager Pharmaceutical Corporation | user2@example.com | None | 2005-09-30 | - | - | - | - | 2025-07-14 |
| Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study | NCT00076440 | Voyager Pharmaceutical Corporation | user2@example.com | None | 2003-12-31 | 2007-03-31 | 2008-03-31 | - | - | 2025-07-14 |